Furthermore, the impact of AMDHD1 on the direct targets of TGF-β signaling and the malignant phenotype of CCA cells was abrogated by TGF-β receptor inhibitors, suggesting that AMDHD1 operates in a TGF-β-dependent manner. The gene discussed is AMDHD1; the disease is cholangiocarcinoma.